Hizentra 20% subcutaneous injection 1g/5mL syringe (YJ code: 6343439G1027, 1g 5mL 1 tube), manufactured by CSL Behring, contains pH4 treated acidic human immunoglobulin (subcutaneous injection). This medication is indicated for primary immunodeficiency (PI) in adults and children aged 2 years and older, and for chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.
Hizentra 20% subcutaneous injection 1g/5mL syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →